))
October 2024: Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
Manage episode 443000620 series 3558363
Контент предоставлен American Psychiatric Association Publishing and American Journal of Psychiatry. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией American Psychiatric Association Publishing and American Journal of Psychiatry или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Dr. Bodyl Brand (Oxford University, UK) joins AJP Audio to discuss the effectiveness of menopausal hormone therapy in preventing psychosis relapse in women with schizophrenia and schizoaffective disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the rest of the October issue of the American Journal of Psychiatry, which focuses on other issues touching psychosis and schizophrenia spectrum disorders.
- 01:05 Brand interview
- 03:08 MHT and potential side effects in schizophrenia treatment
- 06:16 Estrogen and psychosis prophylaxis
- 07:44 MHT effectiveness
- 10:15 Clinical implications
- 11:27 Strengths and limitations
- 13:47 The need for further study
- 15:54 Further research
- 17:24 Kalin interview
- 17:47 Brand et al.
- 20:17 Partanen et al.
- 23:54 Moran et al.
- 26:48 Gallucci et al.
- 30:38 Arion et al.
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.org
202 эпизодов
Поделиться
